Search Critical Intelligence Unit
Debug info
Current query string:
Current Matrix GET variables:
{"resultsTemplateID":"687182","collection":"aci-ciu"} Reset search page
Link to REST URL
1 - 10 of 768 results found.
-
COVID-19 Critical Intelligence Unit: Omicron (B.1.1.529). 1. In brief Omicron (B.1.1.529) updated 27 January 2022. Summary • Omicron (B.1.1.529) was designated a variant of concern by the World Health Organization on 26. November 2021. It was
https://aci.health.nsw.gov.au/__data/assets/pdf_file/0008/696743/Evidence-Check-Omicron.pdf
-
COVID-19 Critical Intelligence Unit: Sotrovimab. 1. In brief Sotrovimab 21 January 2022. Introduction. • Sotrovimab (XEVUDY), is a monoclonal antibody treatment for COVID-19.1 • Monoclonal antibodies are proteins, made in the laboratory, that
https://aci.health.nsw.gov.au/__data/assets/pdf_file/0012/695982/Evidence-Check-Sotrovimab.pdf
-
Budesonide and aspirin for pregnant women with COVID-19
COVID-19 Critical Intelligence Unit: Budesonide and aspirin for pregnant women with COVID-19. 1. In brief Budesonide and aspirin for pregnant women with COVID-19 25 February 2022. Summary • While the early administration of budesonide has been
-
Post-acute and subacute COVID-19 care
1. COVID-19 Critical Intelligence Unit 11 February 2022. Rapid evidence checks are based on a simplified review method and may not be entirely exhaustive, but aim to provide a balanced assessment of what is already known about a specific problem or
-
Evidence in brief - Molnupiravir
COVID-19 Critical Intelligence Unit: Molnupiravir. 1. In brief. Molnupiravir 9 November 2022. Summary. • Molnupiravir (MK-4482/EIDD-2801) is an antiviral medication that is administered orally.1. • Molnupiravir is a potent ribonucleoside
https://aci.health.nsw.gov.au/__data/assets/pdf_file/0009/686466/Evidence-Check-Molnupiravir.pdf
-
Disease modifying treatments for COVID-19 in children
COVID-19 Critical Intelligence Unit: Disease modifying treatments for COVID-19 in children. 1. In brief Disease modifying treatments for COVID-19 in children 11 February 2022. Summary • Most of the trials on disease modifying treatments for
-
Mask type for COVID-19 positive wearer
COVID-19 Critical Intelligence Unit: Mask type for COVID-19 positive wearer. 1. In brief Mask type for COVID-19 positive wearer 11 February 2022. Summary • Throughout the pandemic, masks have been used to protect healthcare workers and the.
-
COVID-19 Critical Intelligence Unit: Paxlovid. 1. In brief. Paxlovid 26 September 2022. Summary. • Paxlovid (PF-07321332/ ritonavir) is an oral antiviral medicine that contains nirmatrelvir tablets. co-packaged with ritonavir tablets.1. • In
https://aci.health.nsw.gov.au/__data/assets/pdf_file/0009/746523/Evidence-Check-Paxlovid.pdf
-
Evidence on AstraZeneca vaccine rollout
Critical Intelligence Unit: Evidence on AstraZeneca rollout. 1. In brief Evidence on AstraZeneca vaccine rollout 11 March 2021. Question: What evidence is emerging regarding the effectiveness of the AstraZeneca vaccine, particularly regarding
-
COVID-19 Critical Intelligence Unit: COVID-19 vaccines and fertility 1 ...
COVID-19 Critical Intelligence Unit: COVID-19 vaccines and fertility. 1. In brief COVID-19 vaccines and fertility 15 September 2021. Summary. • The Royal Australian and New Zealand College of Obstetricians and Gynaecologists and the Australian